Journal Information
Vol. 23. Issue 5.
Pages 234-237 (September - October 1987)
Share
Share
Download PDF
More article options
Vol. 23. Issue 5.
Pages 234-237 (September - October 1987)
Full text access
Enfermedad pulmonar experimental por diisocianato de tolueno
Experimental pulmonary disease induced by toluene diisocyanate
Visits
3468
A. Martinez-Berganza Asensio, F. Escolar Castellon
Servicio de Neumología. Departamento de Medicina. Facultad de Medicina. Universidad de Zaragoza
J.D. Escolar Castellon*, P. Roche Roche*
* Departamento de Anatomía. Facultad de Medicina. Universidad de Zaragoza.
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics

A pesar de que la enfermedad profesional por diisocianato de tulueno (DIT) es conocida desde hace años, todavía se discuten los mecanismos patógenos que intervienen en su desencadenamiento. Para aportar datos al conocimiento de la etiopatogenia, se ha establecido un modelo experimental en ratas.

Se sometió a 8 ratas a una atmósfera de vapores de DIT, de forma ininterrumpida durante 30 días, posteriormente las ratas fueron sacrificadas, se les realizó lavado broncoalveolar (LBA) y estudio histológico que incluía inmunohistioquimia para la detección de IgG.

El LBA mostró un incremento de los linfodtos (38%), lo que coincidía con la infiltración de linfodtos peribronquial y, en menor grado, de los tabiques alveolares. Asimismo, se detectaron depósitos de IgG en las paredes de los capilares alveolares. Todos estos hechos sugieren: la participación de mecanismos de hipersensibilidad retardada tipo III, mediada por IgG; así como, la implicación tanto de las vías aéreas como del parénquima pulmonar. Quedando por aclarar las posibilidades evolutivas de los depósitos de IgG, encontrados en las paredes alveolares.

Even though the occupational disease induced by toluene diisocyanate (DIT) has been known for years, the pathogenetic mechanisms that trigger this condition remain unclear. An experimental model has been developed in the rat in order to provide some insight on the etiopathogenesis of the disease.

Eight rats were mantained on an DIT atmosphere continuosly for 30 days and then killed. Bronchoalveolar lavage (LBA) and histological exam including immunohistochemical assessment for IgG detection were performed in all the animals.

An increased proportion of lymphocytes (39%) was found in the bronchoalveolar lavage, together with a peribronchial lymphocytic infiltration of the alveolar septa. IgG deposits on the alveolar capillary walls were also found. These findings suggest that IgG-mediated type III delayed hypersensitivity mechanisms are involved, and that both airway and pulmonary parenchyma are affected. The final outcome of the IgG deposits found on the alveolar walls is still confuse.

Full text is only aviable in PDF
Bibliografía
[1.]
R.J. Davies, J. Pepys.
Occupational asthma. En Asthma, pp. 190-213
[2.]
B.T. Butcher, R.N. Jones, C.E. O’Neil, H.W. Glindmeyer, J.E. Diem, V. Dharmarajan, H. Weill, J.E. Salvaggio.
Longitudinal study of workers employed in the manufacture of toluene diisocyanate.
Am Rev Respir Dis, 116 (1977), pp. 411-421
[3.]
B.T. Butcher, C.E. O’Neil, M.A. Reed, J.E. Salvaggio.
Radioallergosorbent testing with p-tolyl monoisocyanate in toluene diisocyanate workers.
Clin Allergy, 13 (1983), pp. 31-34
[4.]
M.H. Karol, C. Dixon, M. Brady, Y. Alarie.
Immunologic sensitization and pulmonary hypersensitivity by inhalation of aromatic isocyanates.
Toxicol Appl Pharmacol, 53 (1980), pp. 260-270
[5.]
B.T. Butcher, C.E. O’Neil, M.A. Reed, J.E. Salvaggio.
Radioallergosorbent testing of toluene diisocyanate-reactive individuals using p-tolyl isocyanate antigen.
J Allergy Clin Immunol, 66 (1980), pp. 213-216
[6.]
R.J. Davies, B.T. Butcher, C.E. O’Neil.
The in vitro effect of tuluene diisocyanate on lymphocyte cystic adenosine monophosphate production by isoproterenol, prostaglandin and histamine: a posible mode of action.
J Allergy Clin Immunol, 60 (1977), pp. 233-237
[7.]
B.T. Butcher, R.M. Karr, C.E. O’Neil, M.R. Wilson, V. Dharmarajan, J.E. Salvaggio, H. Weill.
Inhalation challenge and phamacologic studies of toluene diisocyanate (TDI)-sensitive workers.
J Allergy clin Immunol, 64 (1979), pp. 146-152
[8.]
R. Bascom, T.P. Kennedy, D. Levitz, C.R. Zeiss.
Specific bronchoalveolar lavage IgG antibody in hypersensitivity pneumonitis from diphenylmethane diisocyanate.
Am Rev Respir Dis, 131 (1985), pp. 463-465
[9.]
M.H. Karol, H.H. Ioset, Y.C. Alarie.
Tolyl-specific IgE antibodies in workers with hypersensitivity to toluene diisocyanate.
Am Ind Hyg Assoc J, 39 (1978), pp. 454-458
[10.]
K. Tanaka, M. Kawai, N. Maekawa.
Experimental model of asthma by toluene diisocyanate.
Bull Chest Dis Res Inst, 16 (1983), pp. 1-8
[11.]
M.H. Karol.
Concentration-dependent immunologic response to toluene diisocyanate (TDI) following inhalation exposure.
Toxicol Appl Pharmacol, 68 (1983), pp. 229-241
[12.]
R.G. Crystal, P.B. Bitterman, S.I. Rennard, A.J. Hance, B.A. Keogh.
Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract (I).
N Engl J Med, 310 (1984), pp. 154-166
[13.]
R.G. Crystal, P.B. Bitterman, S.I. Rennard, A.J. Hance, B.A. Keogh.
Interstitial lung disease of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract (II).
N Engl J Med, 310 (1984), pp. 235-244
Copyright © 1987. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?